Skip to main content
. 2017 May 12;91(11):e02065-16. doi: 10.1128/JVI.02065-16

FIG 1.

FIG 1

Assessment of neutralization by 100F4 and 65C6 antibodies and control antibody VRC01 using a microneutralization assay (A to C) or plaque reduction assay (D). Neutralization of the antibodies against virus strain SZ06 (A), NE14 (B), and SX06 (C) by a microneutralization assay (A to C) or plaque reduction assay (D) is shown. CPE, cytopathic effect.